Women's decisions regarding tamoxifen for breast cancer prevention: Responses to a tailored decision aid

Breast Cancer Research and Treatment

Volumn 119, Issue 3, 2010, Pages 613-620

  Fagerlin, Angela ^a,b,c   Zikmund Fisher, Brian J ^a,b,c   Smith, Dylan M ^a,b,c   Nair, Vijayan ^b   Derry, Holly A ^c   McClure, Jennifer B ^d   Greene, Sarah ^d   Stark, Azadeh ^e   Alford, Sharon Hensley ^e   Lantz, Paula ^b   Hayes, Daniel F ^b   Wiese, Cheryl ^d   Zweig, Sarah Claud ^e   Pitsch, Rosemarie ^c   Jankovic, Aleksandra ^c   Ubel, Peter A ^a,b,c  

^a Ann Arbor VA HSR and D   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c Center for Behavioral and Decision Sciences in Medicine   (United States)

^d CENTER FOR HEALTH STUDIES   (United States)

^e HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

Breast cancer prevention; Decision aids; Patient education; Tamoxifen

Indexed keywords

TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PREVENTION; CANCER RISK; CONTROLLED STUDY; FEMALE; HUMAN; KNOWLEDGE; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; ONLINE SYSTEM; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT EDUCATION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; WOMEN'S HEALTH;

ADULT; AGED; BREAST NEOPLASMS; DECISION MAKING; DECISION SUPPORT TECHNIQUES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN;

EID: 74849127916     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0618-4     Document Type: Article

References (14)

1. AN Freedman BI Graubard SR Rao W McCaskill-Stevens R Ballard-Barbash MH Gail 2003 Estimates of the number of U.S. women who could benefit from tamoxifen for breast cancer chemoprevention J Natl Cancer Inst 95 7 526 532 1:CAS:528:DC%2BD3sXislyjs78%3D 12671020
2. E Rush Port LL Montgomery AS Heerdt PI Borgen 2001 Patient reluctance toward tamoxifen use for breast cancer primary prevention Ann Surg Oncol 8 7 580 585 10.1007/s10434-001-0580-9
3. D Stacey AM O'Connor C De Grasse S Verma 2003 Development and evaluation of a breast cancer prevention decision aid for higher-risk women Health Expect 6 3 18 10.1046/j.1369-6513.2003.00195.x 12603624 (Pubitemid 36460039)
4. Melnikow J, Paterniti D, Azari R et al. (2005) Preferences of women evaluating risks of tamoxifen (POWER) study of preferences for tamoxifen for breast cancer risk reduction. Cancer 103(10):1996-2005
5. SL Bober LA Hoke RB Duda MM Regan NM Tung 2004 Decision-making about tamoxifen in women at high risk for breast cancer: clinical and psychological factors J Clin Oncol 22 24 4951 4957 10.1200/JCO.2004.05.192 15598980 (Pubitemid 46638620)
6. T Salant PS Ganschow OI Olopade DS Lauderdale 2006 "Why take it if you don't have anything?" Breast cancer risk perceptions and prevention choices at a public hospital J Gen Intern Med 21 779 785 10.1111/j.1525-1497. 2006.00461.x 16808782 (Pubitemid 43973566)
7. KA Metcalfe C Snyder J Seidel D Hanna HT Lynch S Narod 2005 The use of preventative measures among healthy women who carry BRCA1 or BRCA2 mutation Familial Cancer 4 97 103 10.1007/s10689-005-4215-3 15951959 (Pubitemid 40897809)
8. MH Gail LA Brinton DP Byar, et al. 1989 Projecting individualized probabilities of developing breast cancer for white females who are being examined annually J Natl Cancer Inst 81 24 1879 1886 10.1093/jnci/81.24.1879 1:STN:280:DyaK3c%2FnvF2kuw%3D%3D 2593165
9. B Fisher JP Costantino DL Wickerham, et al. 1998 Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study J Natl Cancer Inst 90 18 1371 1388 10.1093/jnci/90.18.1371 1:CAS:528:DyaK1cXmtlelurs%3D 9747868
10. Zikmund-Fisher BJ, Ubel PA, Smith DM et al (2008) Communicating side effect risks in a tamoxifen prophylaxis decision aid: the debiasing influence of pictographs. Patient Educ Couns 73(2):209-214
11. VG Vogel JP Costantino DL Wickerham, et al. 2006 Effects of tamoxifen vs. raloxifene on the risk of developing invasive breast cancer and other disease outcomes J Am Med Assoc 295 23 2727 2741 10.1001/jama.295.23.joc60074 1:CAS:528:DC%2BD28XmtFOltLc%3D (Pubitemid 43920726)
12. Wennberg JE (2002) Promoting Disease Management in Medicare. Testimony before the Subcommittee on Health of the House Committee on Ways and Means, vol 2002
13. M Couper P Miller 2008 Web survey methods Public Opin Q 72 5 831 835 10.1093/poq/nfn066
14. AM O'Connor A Rostom V Fiset, et al. 1999 Decision aids for patients facing health treatment or screening decisions: systematic review Br Med J 319 7212 731 734